Monthly Archives: August 2020
Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment
Prevalence, risk factors, and outcomes of hospitalized patients with COVID-19 presenting as acute pancreatitis
Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn’s disease
Crohn’s Disease (CD) is a chronic gastrointestinal disease resulting from the dysfunctional interplay between genetic susceptibility, the immune system and commensal intestinal microbiota. Emerging evidence suggests that treatment by suppression of the… Continue reading
Monoallelic NTHL1 Loss of Function Variants and Risk of Polyposis and Colorectal Cancer
Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain
We evaluated the efficacy and safety of diet-modulated autologous fecal microbiota transplantation (aFMT) for treatment of weight regain after the weight loss phase. Continue reading
CME Exam 1: Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy
Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia
NEW: MCE Lounge offers additional space for relaxation during work breaks
To offer employees more room to spread out and relax during their work breaks, Vanderbilt University Medical Center has built a new space for employees to eat and rejuvenate in a safe, socially-distanced environment.
The new space, dubbed the MCE Loung… Continue reading
NEW: VUMC awarded $34 million to lead nationwide convalescent plasma study
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a trea… Continue reading
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis
Ustekinumab induces and maintains histologic improvement in patients with ulcerative colitis (UC). The clinical relevance of this endpoint alone, and in combination with endoscopic improvement, is unknown. Continue reading